Exozymes (EXOZ) Non-Current Deffered Revenue (2023 - 2024)
Exozymes (EXOZ) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $137035.0 as the latest value for Q3 2024.
- Quarterly Non-Current Deffered Revenue changed N/A to $137035.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $137035.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $140703.0 for FY2023, N/A changed from the prior year.
- Non-Current Deffered Revenue for Q3 2024 was $137035.0 at Exozymes, down from $140703.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $140703.0 in Q4 2023, with the low at $137035.0 in Q3 2024.